Diagnostic HER2DX-guided treatment for patients with early-stage HER2-positive breast cancer

Projektinformationen

DEFINITIVE

ID Finanzhilfevereinbarung: 101136953

DOI

10.3030/101136953

EK-Unterschriftsdatum 11 Dezember 2023

Startdatum 1 Dezember 2023

Enddatum 30 November 2028

Finanziert unter

• Health

Gesamtkosten

€ 7 999 930,00

EU-Beitrag

€ 7 999 930,00

Koordiniert durch

FUNDACIO DE RECERCA CLINIC BARCELONA-INSTITUT D INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER
Spain

CORDIS bietet Links zu öffentlichen Ergebnissen und Veröffentlichungen von HORIZONT-Projekten.

Links zu Ergebnissen und Veröffentlichungen von RP7-Projekten sowie Links zu einigen Typen spezifischer Ergebnisse wie Datensätzen und Software werden dynamisch von OpenAIRE abgerufen.

Leistungen

Documents, reports (7)

Conclusions of common annual meeting of the ‘Diagnostics and Treatment (diagnostics)’ cluster -1

Report on the conclusions of common annual meeting of the ‘Dianostics and Treatment’ cluster

Clinical guidelines

Summary of developped clinical guidelines based on DEFINITIVE project results - 1

Exploring patient experience in the HER2+ DEFINITIVE clinical trial: a qualitative study

Objectives and methods that will be used to collect DEFINITIVE trial patients experience.

Quality Assurance and Risk Management Plan

Document detailing the Quality Assurance and Risk Management Plan

Plan for ethic-legal monitoring

Document detailing the plan for ethic-legal monitoring & ethical submissions.

Dissemination and Communication Plan 1

Document describing the Dissemination and Communication Plan to ensure full exploitation of the project’s outputs and results.

Clinical guidelines 2

Summary of developped clinical guidelines based on DEFINITIVE project results - 2

Data Management Plan (1)

Data Management Plan 1

Document describing the management plan for DEFINITIVE project

Websites, patent fillings, videos etc. (1)

Project dedicated public website

DEFINITIVE webpage with public and private domains